These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 27256571

  • 21. A novel role for junctional adhesion molecule-A in tumor proliferation: modulation by an anti-JAM-A monoclonal antibody.
    Goetsch L, Haeuw JF, Beau-Larvor C, Gonzalez A, Zanna L, Malissard M, Lepecquet AM, Robert A, Bailly C, Broussas M, Corvaia N.
    Int J Cancer; 2013 Mar 15; 132(6):1463-74. PubMed ID: 22886345
    [Abstract] [Full Text] [Related]

  • 22. Anti-CD45 and anti-CD52 (Campath) monoclonal antibodies effectively eliminate systematically disseminated human non-Hodgkin's lymphoma B cells in Scid mice.
    de Kroon JF, de Paus RA, Kluin-Nelemans HC, Kluin PM, van Bergen CA, Munro AJ, Hale G, Willemze R, Falkenburg JH.
    Exp Hematol; 1996 Jul 15; 24(8):919-26. PubMed ID: 8690051
    [Abstract] [Full Text] [Related]

  • 23. Anti-human CD99 antibody exerts potent antitumor effects in mantle cell lymphoma.
    Takheaw N, Sittithumcharee G, Kariya R, Kasinrerk W, Okada S.
    Cancer Immunol Immunother; 2021 Jun 15; 70(6):1557-1567. PubMed ID: 33215253
    [Abstract] [Full Text] [Related]

  • 24. Anti-CCR7 therapy exerts a potent anti-tumor activity in a xenograft model of human mantle cell lymphoma.
    Somovilla-Crespo B, Alfonso-Pérez M, Cuesta-Mateos C, Carballo-de Dios C, Beltrán AE, Terrón F, Pérez-Villar JJ, Gamallo-Amat C, Pérez-Chacón G, Fernández-Ruiz E, Zapata JM, Muñoz-Calleja C.
    J Hematol Oncol; 2013 Dec 04; 6():89. PubMed ID: 24305507
    [Abstract] [Full Text] [Related]

  • 25. [Therapeutic effect of agonistic CD40 monoclonal antibody combined with CTL on hu-SCID mouse B lymphoma model].
    Zhou H, Xi H, Ma QR, Chen C, Zhang F, Zhang XG, Gu ZJ.
    Zhonghua Zhong Liu Za Zhi; 2007 Mar 04; 29(3):181-5. PubMed ID: 17649632
    [Abstract] [Full Text] [Related]

  • 26. In vitro and In vivo selective antitumor activity of Edelfosine against mantle cell lymphoma and chronic lymphocytic leukemia involving lipid rafts.
    Mollinedo F, de la Iglesia-Vicente J, Gajate C, Estella-Hermoso de Mendoza A, Villa-Pulgarin JA, de Frias M, Roué G, Gil J, Colomer D, Campanero MA, Blanco-Prieto MJ.
    Clin Cancer Res; 2010 Apr 01; 16(7):2046-54. PubMed ID: 20233887
    [Abstract] [Full Text] [Related]

  • 27. Combined administration of rituximab and on 013105 induces apoptosis in mantle cell lymphoma cells and reduces tumor burden in a mouse model of mantle cell lymphoma.
    Prasad A, Shrivastava A, Papadopoulos E, Kuzontkoski PM, Reddy MV, Gillum AM, Kumar R, Reddy EP, Groopman JE.
    Clin Cancer Res; 2013 Jan 01; 19(1):85-95. PubMed ID: 23124440
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. The anti-human leukocyte antigen-DR monoclonal antibody 1D09C3 activates the mitochondrial cell death pathway and exerts a potent antitumor activity in lymphoma-bearing nonobese diabetic/severe combined immunodeficient mice.
    Carlo-Stella C, Di Nicola M, Turco MC, Cleris L, Lavazza C, Longoni P, Milanesi M, Magni M, Ammirante M, Leone A, Nagy Z, Gioffrè WR, Formelli F, Gianni AM.
    Cancer Res; 2006 Feb 01; 66(3):1799-808. PubMed ID: 16452241
    [Abstract] [Full Text] [Related]

  • 31. VCAM-1 is not involved in LPAM-1 (alpha 4 beta p/alpha 4 beta 7) mediated binding of lymphoma cells to high endothelial venules of mucosa-associated lymph nodes.
    Hahne M, Lenter M, Jäger U, Isenmann S, Vestweber D.
    Eur J Cell Biol; 1993 Aug 01; 61(2):290-8. PubMed ID: 7693472
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. AT9283, a novel aurora kinase inhibitor, suppresses tumor growth in aggressive B-cell lymphomas.
    Qi W, Liu X, Cooke LS, Persky DO, Miller TP, Squires M, Mahadevan D.
    Int J Cancer; 2012 Jun 15; 130(12):2997-3005. PubMed ID: 21796626
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.